4-{[(16beta)-17-Hydroxy-16-methyl-3,11,20-trioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoic acid(CAS: 27303-92-0)

The compound is subject to regulatory guidelines such as GHS classification for hazardous chemicals, REACH regulations for the registration, evaluation, authorization, and restriction of chemicals in the European Union, and FDA/EPA requirements for safety and environmental impact assessments. Specific handling and disposal guidelines must comply with local and national regulations.

Alternatives include using similar compounds with similar functional groups or substituents, such as related steroids or other oxoacids. Common reagents or solvents may also be substituted based on the specific synthetic route and desired properties of the final product.

The compound shows increasing interest in research for its potential biological activities, such as hormone-related functions. Market trends indicate growing demand in pharmaceutical and biological research areas. Recent studies focus on its structural and functional characteristics and potential applications.

Waste containing the compound should be collected and disposed of according to hazardous waste regulations. Proper incineration or professional waste disposal services should be used to ensure environmental safety. Precautions include adequate ventilation, personal protective equipment, and proper labeling of waste containers.